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Abstract. We studied the formation of capillary tubes 
by endothelial cells which were sandwiched between 
two fibrin gels under serum-free conditions. After for- 
mation of the overlying fibrin gel, the endothelial cell 
monolayer rearranged into an extensive net of capillary 
tubes. Tube formation was apparent at 5 h and was 
fully developed by 24 h. The capillary tubes were vacu- 
olated, and both intracellular and intercellular lumina 
were present. Maximal tube formation was observed 
with fibrin II (which lacks both fibrinopeptide A and 
B), minimal tube formation with fibrin I (which lacks 
only fibrinopeptide A), and complete absence of tube 
formation with fibrin 325 (which lacks the NH2-termi- 
nal 1315-42 sequence, in addition to fibrinopeptides A 
and B). The inability of fibrin 325 to stimulate capillary 
tube formation supports the idea that 1315-42 plays an 
important role in this process, and its importance was 
confirmed by the finding that exogenous soluble 1315-42 
inhibited fibrin II-induced capillary tube formation. 
This effect was specific for fibrin, since 1315-42 did not 
inhibit tube formation by endothelial cells sandwiched 
between collagen gels. The interaction of the apical sur- 
face of the endothelial cell with the overlying fibrin II 
gel, as opposed to the underlying fibrin gel upon which 
the cells were seeded, was necessary for capillary tube 
formation. These studies suggest that the 1315-42 se- 
quence of fibrin interacts with a component of the api- 
cal cell surface and that this interaction plays a funda- 
mental role in the induction of endothelial capillary 
tube formation. 
NCIO6ENESIS, which is the formation of new blood 
vessels, plays a fundamental role in many physio- 
logical and pathological processes including wound 
healing, tumor growth, and tissue repair following inflam- 
mation  (2,  12,  15,  17).  Because of the broad context in 
which angiogenesis is involved, a variety of in vitro assays 
have been developed that attempt to approximate condi- 
tions which occur in vivo. These models involve the cul- 
ture of endothelial cells on purified matrix proteins such as 
collagen (16, 29, 34, 35), fibrin (18, 30, 34, 35), fibronectin 
(22, 26),  or on complex multimolecular matrices such as 
Matrigel  (20, 23, 35).  Under the appropriate  conditions, 
endothelial cells migrate into the protein matrix gel and 
undergo a shape change, resulting  in the formation of a 
net-like array of capillary-like tubes which may contain lu- 
mina (16, 35). Depending on the model used, this process 
may require cell proliferation and migration  into the gel 
through controlled proteolysis of the matrix proteins (30, 
37, 43). 
Several  specific regulatory  factors,  such  as  fibroblast 
growth factor, platelet-derived growth factor, and vascular 
endothelial growth factor, seem to be involved in the in- 
duction as well as the propagation of angiogenesis (4, 14, 
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17, 26, 31). The interplay of these angiogenic growth fac- 
tors with factors supporting the propagation of angiogene- 
sis,  most  notably specific molecular  components  of the 
extraceUular matrix  (1,  9-11),  appears  to be crucial  for 
morphogenesis  of  endothelial  cells  into  capillary-like 
tubes  (16,  21, 27).  In  many  angiogenic  assays,  capillary 
tube formation requires several days to weeks to occur, 
while in other systems using  specific matrix proteins and 
experimental conditions, tube formation can sometimes be 
observed after I to 2 d (3, 18, 22, 26). Thus, the type of ex- 
perimental model used profoundly affects the regulation 
of angiogenesis under these in vitro conditions. 
Fibrin plays a prominent role in wound healing and tu- 
mor growth (2, 12, 15), and has, therefore, frequently been 
used as a matrix model system designed to test the effect 
of angiogenesis-inducing  compounds (18, 30, 35).  In this 
report, we describe a novel serum-flee system where hu- 
man umbilical  vein endothelial cells (HUVEC)  1 are sand- 
wiched between two fibrin gels.  When the second fibrin 
gel is formed overlying the endothelial cell monolayer, the 
cells rapidly differentiate into capillary tubes. This system 
allows for analyses of the effects of the overlying versus 
underlying fibrin gels and also of the molecular structure 
of fibrin which is active in the induction of capillary tube 
1. Abbreviations used in this paper. HUVEC, human umbilical vein endo- 
thelial cells; RGDS, Arg-Gly-Asp-Ser. 
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which mediates the formation of endothelial cell capillary 
tubes and that the  1315-42 sequence located at the NH2 
terminus of the fibrin 13 chain is responsible for the induc- 
tion of capillary tube formation. 
Materials and Methods 
Reagents 
Endothelial cell basal medium was from Clonetics Corp. (San Diego, CA); 
basic fibroblast  growth factor human recombinant and rat  tail collagen 
(type I) were from Collaborative Biomedical Products (Bedford, MA); and 
Gibco BRL media supplement general (GMS-G) supplement (100X) con- 
taining sodium selenite (0.00067 g/liter), insulin (1.00 g/liter), and transferrin 
(0,55 g/liter) was from GIBCO BRL (Gaithersburg, MD). Lyophilized hu- 
man thrombin and  Atroxin  (Bothrops  atrox venom) were  from  Sigma 
Chemical Co. (St.  Louis, MO). Carrier-free lzsI (NaI in NaOH) was from 
Amersham Corp.  (Arlington Heights, IL). Reagents for electron micros- 
copy were from Polysciences, Inc. (Warrington, PA). Transparent culture 
plate inserts ([2-mm diameter) were from Mlllipore Corp. (Bedford, MA). 
Crotalus atrox protease III was donated by Dr. Andrei Budzynski (Temple 
University, Philadelphia, PA) and Dr. Perumal Thiargarajan (University of 
Texas, Health Science Center at Houston, Houston, TX). Monoclonal anti- 
body 7E3 was a gift from Dr. Barry Coller (Mt. Sinai Medical Center, New 
York). Purified human yon Willehrand factor was a gift from Dr. Luigi De 
Marco (Centro Transfusionale C. R. O., Aviano, Pordenone, Italy). Human 
arterial smooth muscle cells were donated by Dr. Kerri Pratt  (Jefferson 
Medical College of Thomas Jefferson University, Philadelphia, PA). All 
other reagents were purchased from Fisher Scientific Co. (Pittsburgh, PA), 
Sigma Chemical Co., and GIBCO BRL 
Endothelial Cells 
Primary  cultures  of HUVEC  were  isolated  from umbilical cords  and 
maintained in culture as described (28). HUVEC (passages 1-4) were de- 
tached by incubation for 5 min in 0.05% trypsin]0.53 mM EDTA at room 
temperature. The cells were centrifuged at 60 g for 5 min and resuspended 
in serum-free endothelial cell basal medium containing bovine serum al- 
bumin (1%  wt/vol), basic fibroblast  growth factor  (2-5  ng/ml), insulin 
(0.01 mg/mi), transferrin (5.5 p,g/ml), and sodium selenite (6.7 ng/ml). 
Synthetic Peptides 
Peptide 1315-42 was synthesized by the Fmoc strategy of solid-phase syn- 
thesis using a peptide synthesizer (430A; Applied Biosystems, Inc., Foster 
City, CA) and purified by an Applied Biosystems semipreparative system 
equipped with a reverse-phase colunm (C18; Rainin Instrument Co. Inc., 
Woburn, MA). Synthesis of the peptide was carried out at the Jefferson 
Cancer Institute (Philadelphia, PA). The GHRP peptide (1315-18) from 
the NH  2 terminus of the fibrin 13 chain was purchased from Sigma Chemi- 
cal Co. 
Capillary Tube Formation by Endothelial Cells 
Sandwiched between Fibrin Gels 
Fibrinogen was purified from human plasma as previously described (28). 
For some experiments, the purified fibrinogen was chromatographed on 
DEAE-Sepharose (Sigma Chemical Co.) (33) to remove contaminating 
plasminogen, yon Willebrand factor, fibronectin, and factor XIII. The pu- 
rified fibrinogen was free of contaminating yon Willebrand factor and fi- 
bronectin, as demonstrated by Western blot analysis, and of factor XIII, 
as demonstrated by the absence of cross-linking of the ~ chain following 
clot formation induced by thrombin. 
Preparation of  Fibrin H Gels. Fibrinogen (1-3 mg/mi) was dialyzed into 
0.05 M Tris/0.15 M NaC1. To make the underlying fibrin II gel, 225 ~l of fi- 
brinogen solution was placed into each well of a 24-well culture plate, and 
human thrombin (10-30 U/ml in 10×  minimum essential medium) was 
added to a final concentration of i  U of thrombin/mg of fibrinogen. After 
the gels were polymerized (at least 5 rain at 37°C), 1-ml aliquots of endo- 
thelial cells (250,000  cells/ml) suspended in serum-free endothelial cell 
basal medium, supplemented as indicated above, were seeded onto each 
fibrin II gel. After 24 h  the cells had spread to form a confluent mono- 
layer. After aspiration of the culture medium, the same procedure was 
used to generate a second fibrin II gel overlying the apical surface of the 
cells. This fibrin II gel was allowed to polymerize for N5 min at 37°C, and 
then 1-mi  aliquots  of fresh, supplemented, serum-free endothelial  cell 
basal medium were added to each well. In some experiments, overlying 
preformed fibrin or collagen gels, prepared on the reverse side of trans- 
parent culture plate inserts (Millipore Corp.), were gently placed, gel side 
down, on the surface of the cell monolayers. Fresh media were then added 
to the interior of the plastic inserts, as well as to the wells mto which the 
inserts had been placed. 
Preparation ofFibrinlGels. Fibrin  I  gels were  prepared  in  the  same 
manner as fibrin II gels except that Atroxin (10-30 Ixg/ml in sterile dis- 
tilled water) was added in place of thrombin to a final concentration of 1 
~g/mg of fibrinogen. In experiments where fibrin I was generated on top 
of  monolayers established  on  fibrin  II  made  with  thrombin,  residual 
thrombin was neutralized with hirudin (1 U/ml) for 30 min at 37°C. 
Preparation of Fibrin-325 Gels. Fibrinogen 325, which lacks the B131-42 
amino-terminal sequence, was prepared by digestion of fibrinogen with 
protease III from Crotalus  atrox  at an enzyme-to-fibrinogen ratio of 
1:1,000  (36).  The digestion was carried out in 50 mM ammonium bicar- 
bonate (pH 8.0) containing 2 mM EDTA for 3 h at 37°C. The action of the 
protease was terminated by addition of phenylmethylsulfonyl  fluoride to a 
concentration  of  1  raM.  The  fibrinogen  325  was  dialyzed  extensively 
against 50 mM Tris (pH 7.5) and stored at -20°C. Underlying and overly- 
ing fibrin gels were prepared as described above for fibrin II with the fol- 
lowing exceptions. Fibrinogen 325  was in 50 mM Tris (pH 7.5) to which 
were added calcium chloride (final concentration 1 raM) and human fac- 
tor XIII  (final concentration 10 Ixg/ml).  Thrombin (dissolved in 50 mM 
Tris) was added to a final concentration of 10 U/ml, and the fibrin was al- 
lowed to gel for 1-2 h. Control fibrin II and fibrin I gels for these experi- 
ments were prepared in 50 mM Tris with added calcium chloride and fac- 
tor XIII and either thrombin (10 U/ml) or Atroxin (1 Ixg/mi), respectively. 
Capillary Tube Formation by Endothelial Cells 
Sandwiched between Collagen Gels 
Type I collagen from rat tail was diluted to a  concentration of 1 mg/ml, 
and the pH was neutralized by adding one-tenth of the volume of 10 × 
MEM. 250-pA aliquots were immediately added to each well of 24-well cul- 
ture plates and incubated at 37°C until gelation occurred. Endothelial cells 
were seeded on the collagen-coated wells and incubated for 24 h. After as- 
piration  of unattached cells, overlying collagen gels were generated. In 
some experiments, preformed collagen gels were  placed  on top  of the 
monolayers as described above for fibrin II. 
Inhibition of Capillary Tube Formation by Peptides 
or Antibodies 
To study inhibition by the peptides 1315-42 or 1315-18, endothelial cells 
were seeded on either fibrin II gels prepared from fibrinogen (0.5 mg/ml) 
or on collagen gels (1 mg/ml) prepared as described above. After 24 h the 
media were replaced by fresh media containing 1 mM 1315-42 or 1315-18. 
After 1 h of incubation, the media were removed, and preformed fibrin or 
collagen gels on plastic culture plate inserts were gently placed on top of 
the cells. Fresh media containing the same concentration of peptides was 
added to the interior  of the plastic inserts, as well  as to the wells into 
which the inserts had been placed. Controls were treated similarly, but no 
peptide was present in the culture media. To study inhibition by Arg-Gly- 
Asp-Set (RGDS) or 7E3, endothelial cells were seeded on fibrin If gels as 
indicated above. After 24 h the media were replaced by fresh media con- 
taining the appropriate concentrations of RGDS or 7E3 and incubated for 
at least 30 rain. Media were then removed and fibrin II gels, prepared 
from ribrinogen solutions containing RGDS or 7E3, were generated on 
top of the cells. Fresh media containing the agents were then added to the 
wells. 
Microscopic Analysis of Capillary Tubes 
Endothelial cell monolayers and capillary tubes were assessed by phase 
contrast microscopy. Capillary tubes were defined as straight cellular ex- 
tensions joining two cell masses  or branch points. The measurement of the 
number, length, and width of capillary tubes was done by digitalized com- 
puter microscopy (Power Macintosh 7100/66 computer and Nikon Micro- 
phot SA microscope with Sony CCD video camera, using NIH Image, 
Version 1.55, software) of cells that had been fixed and stained with Leu- 
kostate  TM Stainkit (Fisher Scientific). In some experiments, photographs 
were taken of 0.67-ram  2 fields which manifested high visual clarity (18). 
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the length and width of the tubes were measured using a calibrated ruler. 
Statistical analysis was done using the Students t test. For electron micro- 
scopic  analysis,  wells  were washed with PBS,  and the endothelial cell- 
fibrin sandwiches containing reorganized capillary tubes were fixed for 24 h 
at 4°C in a 2.5%  glutaraldehyde/2% paraformaldehyde mixture in 0.1 M 
sodium cacodylate buffer (pH 7.4). The fixed gels were washed with 0.1 M 
sodium cacodylate buffer (pH 7.4) and postfixed in 1% osmium tetroxide 
in 0.1 M sodium cacodylate buffer (pH 7.4) for 1 h at room temperature. 
The samples were dehydrated in a graded series of acetone and embedded 
in Spurr's low-viscosity  embedding media. Thin sections were cut with a 
diamond knife and counterstained with uranyl acetate and lead citrate. 
The stained sections were examined, and photomicrographs  were obtained 
using a  transmission electron microscope  (7000;  Hitachi  Ltd.,  Tokyo, 
Japan). 
SDS-Polyacrylamide Gel Electrophoresis 
Fibrinogen was solubilized,  under reducing conditions, and run using a 
4% polyacrylamide stacking gel and a 10% resolving gel (28). The pro- 
teins in the gel were visualized by staining with Coomassie brilliant blue. 
Some gels  were transferred to nitrocellulose paper,  and Western blots 
were performed using polyclonal antisera against plasminogen, yon Wille- 
brand factor, or fibronectin. Protein bands were visualized  using second- 
ary antibody conjugated with horseradish peroxidase. The polypeptide 
chain composition of fibrin II, fibrin I, and fibrin 325 was assessed by 7% 
SDS-PAGE after disulfide bond reduction (41). 
Results 
HUVEC Monolayers Sandwiched between Fibrin H 
Gels Rapidly Form Capillary Tubes 
The rapid formation of capillary tubes in collagen or fibrin 
gels has been reported to require stimulation of the endo- 
thelial  cells  by  the  tumor  promoter  PMA  (18).  In  the 
present  investigation,  endothelial  cells  sandwiched  be- 
tween fibrin II gels formed capillary tube structures within 
only a few hours, even when cultured in medium devoid of 
PMA.  In  these  experiments,  HUVEC  seeded  on  three- 
dimensional  fibrin  II  gels  established  a  confluent mono- 
layer within 24 h and remained confluent for up to 2  d in 
culture (Fig.  1 a). If an overlying fibrin II gel was gener- 
ated on top of the monolayer, the cells rapidly formed cap- 
illary-like tube structures which could be observed within 
5 h (Fig. 1 b) and which were usually fully developed into 
long, thin tubes by 24 h (Fig. 1 c). The process of capillary 
tube  formation  by endothelial cells  sandwiched  between 
fibrin gels was  specific for endothelial cells,  since human 
arterial smooth muscle cells  did not rearrange into capil- 
lary tubes (Fig. 1 d). 
Figure 1.  Endothelial cells sandwiched between fibrin II gels rapidly form capillary tubes. Cells were grown to confluence on fibrin II 
gels, and an overlying fibrin II gel was then formed on top of the cell monolayers. Before generation of the overlying fibrin II gel, 
HUVEC were present as an intact monolayer (a). Within 5 h of generation of the overlying fibrin II gel, the formation of a netlike array 
of capillary tubes was apparent (b), and by 24 h capillary tube formation was usually fully developed (c). Arterial smooth muscle cells 
failed to form capillary tubes in response to an overlying fibrin II gel (d). Bars, 120 ixm. 
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tween fibrin II gels manifest intercel- 
lular and intracellular lumina. Speci- 
mens were fixed for 24 h at 4°C in a 
2.5%  glutaraldehyde/2%  paraform- 
aldehyde  solution,  postfixed  in  1% 
osmium tetroxide, dehydrated in ace- 
tone, and embedded in Spurr's low- 
viscosity embedding media. Thin sec- 
tions  were  cut  and  counterstained 
with uranyl acetate and lead citrate. 
In this figure, an endothelial capillary 
tube has been sectioned along its lon- 
gitudinal axis to reveal both an inter- 
cellular lumen (**) formed by the in- 
terdigitation  of  several  endothelial 
cell processes as well as a putative in- 
tracellular  lumen  (*)  present  within 
the  cytoplasm of a  single  cell.  Note 
that the  intracellular  lumen  is  lined 
by a cell membrane. Both lumina are 
filled with cellular debris (D). The in- 
tercellular junctions between individ- 
ual endothelial cells can be seen (ar- 
rows). The underlying and overlying 
fibrin gels (F) are shown. The under- 
lying fibrin gel appears much denser. 
×10,000. Bar, 6 i~m, 
By light microscopy, the capillary tubes were observed 
to contain vacuoles and channels and were very similar in 
overall appearance  to endothelial  cell capillary tubes ob- 
served by other investigators (16, 18). By electron micros- 
copy, debris-filled intercellular  lumina, formed by the in- 
terdigitation of several endothelial cells, as well as distinct 
intracellular lumina could be observed (Fig. 2). Proteolysis 
of the  fibrin  was not required  for tube  formation,  since 
aprotinin did not inhibit tube formation and the fibrin gels 
demonstrated intact a,  [3, and ~/chains in SDS-polyacryl- 
amide  gels (not shown). Finally, tube  formation was not 
due to contaminating proteins  such as fibronectin, factor 
XIII, or von Willebrand  factor,  since  depletion  of these 
proteins  from fibrinogen was without effect on tube  for- 
mation (not shown). 
Since thrombin itself has been reported to cause endo- 
thelial cell retraction (24), experiments were performed to 
delineate the potential effect of thrombin from that of the 
fibrin II gel. When thrombin was added to medium overly- 
ing an intact  endothelial  cell monolayer established  on a 
fibrin II gel, rearrangement  of the cells was not observed 
and the cells remained as a  monolayer (not shown), indi- 
cating that thrombin was not responsible for the formation 
of capillary tubes induced by fibrin II gels. Furthermore, 
endothelial  cells sandwiched between preformed fibrin II 
gels that had been previously exposed to hirudin (1 U/ml 
for 30 min),  to neutralize  the  thrombin,  formed normal- 
appearing capillary tubes (not shown). 
The avfl3 Integrin Receptor Is Not Essential for the 
Formation of Capillary Tubes by Sandwiched HUVEC 
The txvl33 integrin, which is the major integrin receptor of 
endothelial cells currently known to interact with fibrino- 
gen (1, 9-11), has been shown to play a role in regulating 
angiogenesis under some experimental  conditions (6,  18). 
We therefore analyzed the role of the av[~3 integrin recep- 
tor under  our experimental  conditions  in which capillary 
tube formation is induced by sandwiching the endothelial 
cells between two fibrin gels in a serum-free system that is 
devoid of phorbol esters. When HUVEC were sandwiched 
between fibrin II gels and incubated in medium without or 
with  RGDS  or  the  monoclonal  antibody  7E3  directed 
against  e~vl~3, the  formation  of capillary  tubes  was  unal- 
tered (Table I). Increasing the concentration of 7E3 to 30 
ixg/ml had  an  apparently  slight  enhancing  effect on tube 
formation similar  to that  reported  by other investigators 
(18).  Overall, our data indicate that disruption of etvl33 in- 
tegrin interaction with fibrin did not inhibit capillary tube 
formation by cells sandwiched between two fibrin II gels. 
HUVEC Monolayers Sandwiched between Fibrin I Gels 
Fail to Form Capillary Tubes 
Fibrin II is formed from fibrinogen by thrombin cleavage 
of fibrinopeptide A  from the As chain and fibrinopeptide 
B  from the Bfl chain, resulting in the generation of the 
Table L Effects of  RGDS or 7E3 on Capillary Tube Formation 
Capillary tube  parameters* 
Treatment  Numbed  Length  Width 
p/n  /un 
Control  26  ±  7  122  -  24  25  _  6 
RGDS150pma  25  ±  7  117  ±  19  26  ±  7 
RGDS500p~m  23  _  9  102  ±  21  22  ±  3 
7E310p.g/ml  27  ±  7  124  ±  17  25  ±  6 
*Values are means + SD of at least 10 expenments  for control  and 4-7 experiments 
for treatments. 
*Number  of  tubes in 0.3 mm  2. 
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of structurally  distinct  forms of fi- 
brin. Fibrin II (FII) and fibrin (F/) 
were prepared by treatment of fi- 
brinogen  (fg)  with  thrombin  or 
Atroxin,  respectively.  Fibrinogen 
325 was prepared by treatment of 
fibrinogen  with  protease III. Sam- 
ples were run on a 7% polyacryla- 
mide  gel  and  stained  with  Coo- 
massie blue. In fibrin II and fibrin I, 
the cx chain migrates faster than the 
Act  chain  of  fibrinogen  due  to 
cleavage of fibrinopeptide A. In fi- 
brin II, the  13 chain  also  migrates 
faster that the B[~ chain of fibrin- 
ogen  due  to  cleavage  of  fibrino- 
peptide B. The [3 chain  of fibrin 325 migrates just above the 
chain due to the absence of B131--42. 
and 13 chains of fibrin II, respectively (25, 39). Thus in fi- 
brin II, new NH2 termini are generated for both the et and 
chains, relative to fibrinogen. In contrast, fibrin I can be 
formed from fibrinogen by Atroxin  cleavage of only fi- 
brinopeptide A; thus, the B[3 chain of fibrin I is the same 
as that in fibrinogen. These biochemical differences, which 
can be assessed by SDS-polyacrylamide gel electrophore- 
sis (Fig. 3), account for structural differences between po- 
lymerized fibrin I and fibrin II (32), and may provide clues 
as to the structural features of fibrin that are important for 
capillary tube formation. 
As reported by other investigators (7), endothelial cells 
seeded onto fibrin I gels remained rounded after 2 h of in- 
cubation (not shown), but by 24 h  a confluent monolayer 
of endothelial cells was established on fibrin I gels (Fig. 4 
a), indicating that fibrin I is capable of providing sufficient 
support for the eventual establishment of an intact cellular 
monolayer. Cell spreading on fibrin I gels was integrin me- 
diated, since it was markedly inhibited by RGDS (Fig. 4 b) 
or 7E3 (not shown). Whether the cell spreading on fibrin I 
in  the  absence of antiintegrins  was supported by the re- 
lease  of yon Willebrand  factor from the  cells or was di- 
rectly  supported  by  the  fibrin  I  molecule  itself  is  not 
known. Nevertheless, the spreading of endothelial cells on 
the  fibrin I  gels  allowed the  study of potential capillary 
tube formation using the fibrin-gel sandwich technique. 
Endothelial cell monolayers sandwiched between fibrin 
I  gels manifested a variable range of responses from one 
experiment  to  the  next.  The  extremes  ranged  from  no 
change  in  the  confluent  cobblestone  appearance  of the 
monolayer  (not  shown)  to  the  formation  of attenuated 
tubelike structures (Fig. 5) that were very transient. For- 
mation of these quasi tube structures was not a  result of 
yon Willebrand factor secreted by the cells, since the addi- 
tion  of purified von Willebrand  factor to  the  fibrinogen 
used to generate the fibrin I gels did not result in capillary 
tube  formation (not  shown).  Thus,  there  must be struc- 
tural features in fibrin II, not present in fibrin I, which play 
an important role in the formation of endothelial cell cap- 
illary tubes. 
Because it was possible that the Atroxin used to gener- 
ate fibrin I gels inhibited the formation of capillary tubes, 
control experiments were performed in which fibrin II gels 
were  made  using  a  mixture  of  thrombin  plus  Atroxin. 
These fibrin II gels, which had the same structure as fibrin 
II gels made with thrombin alone, induced capillary tube 
formation that was indistinguishable from tubes formed in 
fibrin II gels in the absence of Atroxin (not shown), indi- 
cating  that  Atroxin was  not  inhibitory  to  capillary tube 
formation. 
The Overlying Fibrin II Gel Induces the Formation of 
Capillary Tubes 
To determine whether the morphogenesis of the endothe- 
lial cells into capillary tube structures was triggered by the 
interaction of the cells with the underlying fibrin gel used 
for seeding or with the overlying fibrin gel formed on top 
of the cells, experiments were done using fibrin II as the 
underlying gel and either fibrin II or fibrin I as the overly- 
ing gel. Under these conditions, the interaction of the cells 
with the overlying gels could be assumed to be responsible 
Figure 4.  Endothelial cell spreading on a fibrin I gel is mediated by cellular integrins. HUVEC were seeded onto a fibrin I gel in the ab- 
sence (a) or presence (b) of 500 tzm RGDS. After 24 h of culture, control cells established  a confluent  monolayer, while RGDS com- 
pletely prevented cell spreading. Bar, 120 ~m. 
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wiched  between  fibrin  I  gels fail to 
form capillary tubes.  HUVEC  were 
seeded onto fibrin I gels and cultured 
to confluence. Overlying fibrin I gels 
were  then  generated  atop  the  cells 
and the incubation was continued for 
an  additional  24  h.  The  HUVEC 
formed attenuated and transitory semi- 
tube-like structures. Bar, 120 ~m. 
for  the  observed  changes  in  cellular  morphology,  since 
cells  sandwiched  between  two  fibrin  I  gels  did  not  form 
capillary tubes. When fibrin II was generated on top of the 
cells, well-developed capillary tubes were always seen (see 
Fig. 1 c). In contrast, when fibrin I was generated on top of 
the cells that had been seeded on fibrin II, a high degree of 
interexperimental  variability  was  seen.  In  some  experi- 
ments, the  endothelial  cells remained  as an intact  mono- 
layer  (not  shown;  identical  to  Fig.  1  a),  while  others 
yielded  capillary tubes  that appeared  blunted  in develop- 
ment (Fig. 6). These tubes were very transient and usually 
degenerated  over the following day in culture. These find- 
ings  emphasize  the  importance  of the  overlying  fibrin  II 
gel  in  the  formation  of capillary  tubes  and  indicate  that 
structural  determinants  present  in fibrin II, but  not in  fi- 
brin I, are important for the optimal formation of capillary 
tubes. 
The ~15-42 Sequence in Fibrin H Is Necessary for 
Endothelial Cell Capillary Tube Formation 
The 1315--42 sequence  mediates the spreading of endothe- 
lial cells on fibrin II (7, 13). In order to assess whether this 
sequence  is also important  for the  morphogenesis  of en- 
dothelial  cells into capillary tubes,  experiments  were per- 
formed using fibrin 325, which is generated  from fibrino- 
gen 325 which lacks the amino terminal B131--42 sequence 
(Fig. 3). In these experiments, capillary tube formation did 
not  occur  when  endothelial  cell  monolayers  were  estab- 
lished  on fibrin II, and  an overlying fibrin gel was gener- 
ated  from  fibrinogen  325.  Conversely,  when  monolayers 
were  established  on  fibrin  325  and  an  overlying fibrin  II 
gel was formed,  the  cells  rearranged  into  capillary  tubes 
within 24 h  (not shown). The same result was obtained us- 
ing preformed fibrin gels that were adherent  to plastic in- 
Figure  6.  Endothelial  cells  seeded 
on a fibrin II gel with an overlying fi- 
brin  I  gel  form  blunted  capillary 
tubes. HUVEC monolayers were es- 
tabfished  on  fibrin  II  gels  and  an 
overlying fibrin I gel was then gener- 
ated. The cells formed linear tubelike 
projections  which  ended  blindly 
(arrows) without  establishing  many 
cell-cell contacts and without the re- 
sulting  netlike  appearance  of  tubes 
sandwiched  between  fibrin  II  gels 
(see Fig. 1). 
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tion. HUVEC monolayers (a) were established on fibrin II gels and overlaid with preformed fibrin-325 gels or (b) where established on 
fibrin-325 gels and overlaid with preformed fibrin II gels. With fibrin-325 on top, the ceils remained as a monolayer (a), and with fibrin 
II on top the cells formed capillary tubes (b). Bar, 120 Ixm. 
serts and then placed on top of the endothelial cell mono- 
layer. When endothelial monolayers were established on 
fibrin II and a preformed fibrin-325 gel placed on top, the 
monolayer remained intact (Fig.  7 a).  In  contrast, when 
monolayers  were  established  on  fibrin  325  and  a  pre- 
formed fibrin II gel was placed on top, the cells reorga- 
nized into capillary tubes (Fig. 7 b). 
The importance of the [315--42 sequence within fibrin II 
in the induction of capillary tube formation was directly 
demonstrated by the ability of excess soluble [315-42 pep- 
tide to inhibit capillary tube formation induced by fibrin 
II. The addition of 1 mM [315--42 to the culture media be- 
fore the addition of a prepolymerized overlying fibrin II 
gel  significantly reduced  the  number  and  length  of the 
tubes, while significantly increasing tube diameter (Table 
II). The tetrapeptide GHRP ([315-18) did not induce simi- 
lar alterations, nor did [315-42  alter capillary tube forma- 
tion by endothelial cells sandwiched between collagen gels 
(not  shown),  indicating  the  specificity of the  fibrin  II- 
endothelial cell interaction. 
In addition to establishing the importance of the [315-42 
sequence  in  fibrin  II-induced  endothelial  cell  capillary 
tube formation, the above results also indicate that throm- 
bin was not responsible for tube formation since the pre- 
formed fibrin-325 gels contained active thrombin, yet did 
not induce tube formation. They also corroborate the ob- 
servation that it is  the overlying fibrin II gel interacting 
with the apical surface of the endothelial cell monolayer 
Table II. Inhibition of Fibrin lI-induced Capillary  Tube 
Formation by Soluble fl15-42 
Capillary tube parameters* 
Treatment  Numbed  Length  Width 
p/n 
Control  12.7  ±  4.3  101.0  ±  24.4  7.6  ±  1.6 
1315-42  7  __-  1.4  §  66.7  ___  14.8  §  12.8  -  2.43 
*Values are means -.+ SD of at least four experiments. 
~:Number of tubes in 0.3 mm  2. 
§ Significantly  different from control; P  <  0.05. 
which is responsible for induction of the morphogenesis 
process. 
Discussion 
In this work, we demonstrate that HUVEC, when sand- 
wiched  between  two  fibrin  II  gels,  promptly rearrange 
into an extensive network of capillary-like tubes.  These 
structures were clearly discernible as early as 5 h after for- 
mation of the overlying fibrin II gel and remained intact 
for up to  3  d.  Consistent with  the  features of capillary 
tubes studied by others (16, 18), light microscopy revealed 
the presence of vacuoles and channels within the tubes 
that, by electron microscopy, were seen to contain both 
intercellular and intraceUular lumina which were partially 
filled with cellular debris. The formation of these struc- 
tures was directly supported by the fibrin II molecule it- 
self, since the depletion of contaminating proteins, such as 
fibronectin, von Willebrand factor, factor XIII, and plas- 
minogen, from the purified fibrinogen used to generate 
the fibrin II did not hinder capillary tube formation. More- 
over, %[33 interaction with von Willebrand factor, which 
may have been secreted by the cells in response to fibrin 
II (38), did not appear to be responsible for tube forma- 
tion since the addition of exogenous von Willebrand fac- 
tor to the fibrinogen used to form the fibrin I gels did not 
promote tube formation. 
A unique and important finding of this study is that gen- 
eration of capillary tubes  was  optimally supported  by a 
specific form of fibrin, namely, fibrin II. Tube formation 
was  only minimally supported by fibrin I  and never ob- 
served with fibrin 325. In vivo, fibrin II formation predom- 
inates over fibrin I formation, although both forms have 
been  demonstrated  in  vascular  lesions  (5).  The  newly 
formed fibrin monomers are susceptible to the action of 
plasmin, which cleaves [315--42 (42) generating fibrin 325, 
which  manifests  markedly  delayed  polymerization  (40). 
Fibrin 325  can also be generated experimentally from fi- 
brinogen 325,  a  fibrinogen derivative prepared by treat- 
ment of fibrinogen with protease III from Crotalus atrox, 
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nus of each fibrinogen B13 chain thereby reducing the mo- 
lecular mass to 325 kD (36). In addition to its role in fibrin 
polymerization, the 1315-42 sequence has also been shown 
to inhibit fibrinogen binding to platelets via a mechanism 
which may involve its binding to fibrinogen, as opposed to 
the platelet fibrinogen receptor GPIIb/IIIa (8). It also me- 
diates fibrin II-induced release of yon Willebrand factor 
from endothelial cells (13, 38), and accounts, at least in 
part, for the ability of fibrin II to support spreading of en- 
dothelial cells (7, 13). Our demonstration of the inability 
of fibrin I or fibrin 325 to trigger endothelial cell capillary 
tube formation and the ability of soluble 1315-42 to inhibit 
tube formation induced by fibrin II, but not by collagen, 
indicates  the  importance  of the  1315-42 sequence  as  a 
structural  determinant of fibrin II that may account for 
this activity. 
Our observation that endothelial cells fail to spread on 
fibrin I within 2 h is in agreement with findings of other in- 
vestigators (7). However, our demonstration of the capac- 
ity of endothelial cells to spread on fibrin I  after 24 h al- 
lowed  us  to  study  the  formation  of capillary  tubes  by 
endothelial cell monolayers sandwiched between fibrin I 
gels. Our results showing that RGDS and the monoclonal 
antibody 7E3 disorganize endothelial cell monolayers plated 
on fibrin I, but not on fibrin II, indicate that the txv133  inte- 
grin  plays  a  major  role  in  maintaining  the  integrity  of 
endothelial cell monolayers plated on fibrin I, but not on 
fibrin II. These data further indicate that other determi- 
nants within fibrin II, notably the 1315-42 sequence, are ca- 
pable  of supporting  endothelial cell spreading  as  previ- 
ously reported (7, 13). 
The high level of expression of av133 in granulation tissue 
indicates that this integrin is involved in angiogenesis (6). 
Indeed, in the chick chorioaUantoic membrane, antibodies 
against o%133 have a potent inhibitory effect on the forma- 
tion of new blood vessels (6). In contrast to this inhibitory 
effect, PMA-induced formation of capillary tubes on col- 
lagen or fibrin gels is enhanced by antibodies to the a2131 
integrin or the av133 integrin, respectively (18). Thus, the 
role of Otv133 in angiogenesis is complex and the observed 
effect on capillary tube formation may depend, in part, on 
the experimental conditions. Indeed, in our system, nei- 
ther RGDS nor the antibody 7E3 against the 133 integrin 
receptor complex had any noticeable effect on the forma- 
tion of capillary tubes. The different results which we ob- 
tained in comparison with other investigators (6, 18) may 
possibly be due to the absence of PMA in our serum-free 
system utilizing cells sandwiched between fibrin gels.  It 
may  be  that  the  simplicity of this  system  removes  un- 
known factors which may be important for etv133-mediated 
capillary tube formation. 
Angiogenesis assays frequently make use of complex bi- 
ologically synthesized matrices such as Matrigel, in which 
laminin seems to play a predominant role in formation via 
the expression of three sequences within its structure (23). 
An Arg-Gly-Asp sequence in the A chain supports cell at- 
tachment, while the YIGSR sequence, of the B1 chain in- 
duces capillary tube formation. The latter effect may be 
mediated by a specific interaction with a 67/32-kD endo- 
thelial cell surface protein (23). A  third region of laminin, 
the SIKVAV sequence located in the A  chain, promotes 
migration, invasion of Matrigel, and growth and branching 
of capillary tubes (19). Thus interactions between matrix 
proteins and cell surface receptors may underlie the for- 
mation of capillary tubes (21). In this regard, it is most in- 
teresting  that  the  t315-42  sequence  of fibrin  has  been 
shown to bind to a 130-kD glycoprotein expressed at the 
endothelial cell surface (13), and it is conceivable that fi- 
brin II interaction with this receptor may initiate capillary 
tube formation. 
In our experiments, proteolysis of matrix proteins was 
not required for the formation of capillary tubes, presum- 
ably  because  the  monolayers  are  instantaneously  sand- 
wiched between two fibrin gels and do not need to migrate 
into the gel in order to become surrounded by the matrix. 
Most importantly, our studies demonstrate that contact of 
fibrin  II  with  the  apical  aspect  of the  endothelial  cell 
monolayer is crucial for the induction of morphogenetic 
changes. This finding is consistent with other studies that 
have demonstrated that the interaction of collagen with 
the apical surface of endothelial cells also induces the for- 
mation of capillary tubes (35). However, we observed that 
exogenous  soluble  1315-42 peptide  inhibited  fibrin  II- 
induced tube formation by 45%, while collagen-induced 
tube formation was unaffected. This finding indicates the 
specificity of interaction of fibrin with the endothelial cell 
surface. 
In summary, we describe a  new in vitro assay for the 
study of capillary tube formation by endothelial cells sand- 
wiched between two fibrin gels in serum-free medium. The 
induction of capillary morphogenesis is dependent on the 
structure of fibrin, with optimal tube formation occurring 
with fibrin II, minimum tube formation with fibrin I, and 
complete absence of tube formation with fibrin 325.  Ex- 
cess soluble [315-42 peptide was able to inhibit fibrin II- 
induced capillary tube formation, suggesting that interac- 
tion of the NH2 terminus of the fibrin II 13 chain with the 
apical surface of the endothelial cells plays a principal role 
in promoting tube formation. 
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